Form 4: MYGN COO Verratti's Tax-Related Stock Disposition

Myriad Genetics Chief Operating Officer Mark Verratti disposed of 1,085 shares of common stock to cover tax obligations related to restricted stock unit vesting.

Summary

• Mark Verratti, Chief Operating Officer of Myriad Genetics Inc. (MYGN), reported a disposition of common stock.
• The transaction involved 1,085 shares of common stock, withheld by the company to satisfy tax withholding obligations.
• This disposition was in connection with the vesting of restricted stock units granted to Mr. Verratti.
• The shares were disposed of at a price of $7.77 per share.
• Following this transaction, Mr. Verratti beneficially owns 381,826 shares of Myriad Genetics common stock.
• The price per share was determined based on the closing price of Myriad common stock on September 19, 2025.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary insider transaction for tax withholding purposes, which is neutral in sentiment and does not indicate any positive or negative operational or financial developments for the company.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction related to compensation and tax obligations, and it does not provide specific insights into broader industry trends or competitive positioning for Myriad Genetics.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in management's discretionary view of the company's prospects.
• Employees: No direct impact mentioned.

Key Dates

Keywords

MYRIAD GENETICS, MYGN, Form 4, Insider Transaction, Stock Disposition, Tax Withholding, Mark Verratti, Chief Operating Officer, Restricted Stock Units